Executive Summary: HEXO's (HEXO) stock price skyrocketed 47.83% last Monday seemingly without a catalyst. A deep-dive into the firm's capabilities heavily suggests that the move was due to HEXO's receipt of the cannabis 2.0 license, whose economic value the firm is uniquely positioned to fully extract. My analysis and valuation imply a fair value of CAD 2.24, a 64% upside to the current share price.
The Driver of Stock Price Surge
The firm recently received approval from Health Canada to produce and sell cannabis 2.0 products from its Belleville facility and its Truss